Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2015 08:00 ET | Source: CareDx, Inc.

CareDx Appoints John J. Sninsky, Ph.D. as Chief Scientific Officer

BRISBANE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
December 12, 2014 16:50 ET | Source: CareDx, Inc.

CareDx Presents HeartBrothers Foundation with a Grant to Support Heart Transplant Education and Patient Support in New England

BRISBANE, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
November 18, 2014 17:44 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
November 10, 2014 16:05 ET | Source: CareDx, Inc.

CareDx, Inc. Reports Third Quarter 2014 Financial Results

BRISBANE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
October 27, 2014 08:01 ET | Source: CareDx, Inc.

CareDx to Release Third Quarter 2014 Financial Results and Host Conference Call on Monday, November 10, 2014

BRISBANE, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
October 03, 2014 11:12 ET | Source: CareDx, Inc.

CareDx to Present at the BIO Investor Forum

BRISBANE, Calif., Oct. 3, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
August 27, 2014 16:01 ET | Source: CareDx, Inc.

CareDx, Inc. Reports Second Quarter 2014 Financial Results

BRISBANE, Calif., Aug. 27, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA) a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
August 14, 2014 09:00 ET | Source: CareDx, Inc.

CareDx to Release Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 27, 2014

BRISBANE, Calif., Aug. 14, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
July 31, 2014 16:34 ET | Source: CareDx, Inc.

CareDx and Allegheny General Hospital Launch Research Study of Novel Test to Screen Heart Transplant Recipients for Signs of Rejection

BRISBANE, Calif. and PITTSBURGH, July 31, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA) a molecular diagnostics company focused on the development and commercialization of clinically...
July 28, 2014 16:01 ET | Source: CareDx, Inc.

CareDx Presents Cell-Free DNA Biomarker Results in Heart and Kidney Transplant Recipients at the World Transplant Congress

BRISBANE, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...